Nuveen LLC’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.16M Sell
129,511
-23,260
-15% -$1.29M ﹤0.01% 1705
2025
Q1
$7.39M Buy
+152,771
New +$7.39M ﹤0.01% 1722